These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 4903041

  • 1. [Diseases caused by iron metabolism disorders and their therapy].
    Stacher A.
    Wien Z Inn Med; 1969; 50(3):89-105. PubMed ID: 4903041
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Hemochromatosis].
    Simon M, Hespel JP, Brissot P, Fauchet R, Edan G, Le Reun M, Le Mignon L, Genetet B, Bourel M.
    Ann Med Interne (Paris); 1981; 132(6):413-33. PubMed ID: 7032384
    [No Abstract] [Full Text] [Related]

  • 6. [Iron storage disease].
    Heilmeyer L.
    Munch Med Wochenschr; 1967 Mar 31; 109(13):677-84. PubMed ID: 5631729
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Syndromes of iron overload.
    al-Rashid RA.
    Clin Toxicol; 1971 Dec 31; 4(4):571-8. PubMed ID: 5164170
    [No Abstract] [Full Text] [Related]

  • 9. A clinical evaluation of serum ferritin as an index of iron stores.
    Lipschitz DA, Cook JD, Finch CA.
    N Engl J Med; 1974 May 30; 290(22):1213-6. PubMed ID: 4825851
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Storage iron and desferrioxamine.
    Fielding J.
    Proc R Soc Med; 1970 Dec 30; 63(12):1218-21. PubMed ID: 5490766
    [No Abstract] [Full Text] [Related]

  • 12. Disorders of iron metabolism.
    Clumming RL.
    Practitioner; 1978 Aug 30; 221(1322):184-92, 275. PubMed ID: 724612
    [No Abstract] [Full Text] [Related]

  • 13. [Use of desferal in treatment of sideroses of different origin. (Literature review)].
    Turbina NS.
    Probl Gematol Pereliv Krovi; 1968 Jul 30; 13(7):47-52. PubMed ID: 4898933
    [No Abstract] [Full Text] [Related]

  • 14. Effect of desferrioxamine B. A new iron eliminating agent, on cases of secondary haemosiderosis in children.
    el-Gholmy A, Khalifa AS, Rahman YA, el-Bagoury I.
    J Trop Med Hyg; 1969 Jan 30; 72(1):22-6. PubMed ID: 5773810
    [No Abstract] [Full Text] [Related]

  • 15. [Anemia and iron therapy].
    Diez-Ewald M.
    Invest Clin; 1992 Jan 30; 33(4):135-6. PubMed ID: 1303672
    [No Abstract] [Full Text] [Related]

  • 16. Desferal therapy in iron storage disease.
    Thompson RB, Owen DM, Bell WN.
    Am J Med Sci; 1967 Apr 30; 253(4):453-60. PubMed ID: 6021380
    [No Abstract] [Full Text] [Related]

  • 17. [Iron administration in pregnancy--general prevention or indicated therapy].
    Winkler UH.
    Zentralbl Gynakol; 1987 Apr 30; 109(6):369-72. PubMed ID: 3591071
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Iron metabolism and iron chelation in the thalassaemia disorders.
    Pippard MJ.
    Haematologica; 1990 Apr 30; 75 Suppl 5():66-71. PubMed ID: 2086383
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.